 |
|
25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population
Michal L. Melamed, MD, MHS;
Erin D. Michos, MD, MHS;
Wendy Post, MD, MS;
Brad Astor, PhD
Arch Intern Med. 2008;168(15):1629-1637.
Background In patients undergoing dialysis, therapy with calcitriol or paricalcitol or other vitamin D agents is associated with reduced mortality. Observational data suggests that low 25-hydroxyvitamin D levels (25[OH]D) are associated with diabetes mellitus, hypertension, and cancers. However, whether low serum 25(OH)D levels are associated with mortality in the general population is unknown.
Methods We tested the association of low 25(OH)D levels with all-cause, cancer, and cardiovascular disease (CVD) mortality in 13 331 nationally representative adults 20 years or older from the Third National Health and Nutrition Examination Survey (NHANES III) linked mortality files. Participant vitamin D levels were collected from 1988 through 1994, and individuals were passively followed for mortality through 2000.
Results In cross-sectional multivariate analyses, increasing age, female sex, nonwhite race/ethnicity, diabetes, current smoking, and higher body mass index were all independently associated with higher odds of 25(OH)D deficiency (lowest quartile of 25(OH)D level, <17.8 ng/mL [to convert to nanomoles per liter, multiply by 2.496]), while greater physical activity, vitamin D supplementation, and nonwinter season were inversely associated. During a median 8.7 years of follow-up, there were 1806 deaths, including 777 from CVD. In multivariate models (adjusted for baseline demographics, season, and traditional and novel CVD risk factors), compared with the highest quartile, being in the lowest quartile (25[OH]D levels <17.8 ng/mL) was associated with a 26% increased rate of all-cause mortality (mortality rate ratio, 1.26; 95% CI, 1.08-1.46) and a population attributable risk of 3.1%. The adjusted models of CVD and cancer mortality revealed a higher risk, which was not statistically significant.
Conclusion The lowest quartile of 25(OH)D level (<17.8 ng/mL) is independently associated with all-cause mortality in the general population.
Author Affiliations: Division of Nephrology, Department of Medicine, and Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Melamed); Divisions of Cardiology (Drs Michos and Post) and General Internal Medicine (Dr Astor), Department of Medicine, Johns Hopkins University, School of Medicine, Baltimore, Maryland; and Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore (Drs Post and Astor).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTERS
25-Hydroxyvitamin D Levels and All-Cause Mortality
Armin Zittermann and William B. Grant
Arch Intern Med. 2009;169(11):1075-1076.
EXTRACT
| FULL TEXT
25-Hydroxyvitamin D Levels and All-Cause Mortality—Reply
Michal L. Melamed, Erin D. Michos, and Brad Astor
Arch Intern Med. 2009;169(11):1076.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Relation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular Mortality
Tonelli et al.
Circulation 2009;120:1784-1792.
ABSTRACT
| FULL TEXT
Vitamin D: An Evidence-Based Review
Kulie et al.
J Am Board Fam Med 2009;22:698-706.
ABSTRACT
| FULL TEXT
Vitamin D Status and the Risk of Cardiovascular Disease Death
Kilkkinen et al.
Am J Epidemiol 2009;170:1032-1039.
ABSTRACT
| FULL TEXT
Vitamin D and Health: Can Too Much Be Harmful?
Davis
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2009;3:407-408.
Dietary vitamin D and cancers of the oral cavity and esophagus
Lipworth et al.
Ann Oncol 2009;20:1576-1581.
ABSTRACT
| FULL TEXT
Current Impediments to Acceptance of the Ultraviolet-B-Vitamin D-Cancer Hypothesis
GRANT and BOUCHER
Anticancer Res 2009;29:3597-3604.
ABSTRACT
| FULL TEXT
Calcium, Vitamin D and Cancer
PETERLIK et al.
Anticancer Res 2009;29:3687-3698.
ABSTRACT
| FULL TEXT
Epidemiology of Vitamin D Insufficiency and Cancer Mortality
PILZ et al.
Anticancer Res 2009;29:3699-3704.
ABSTRACT
| FULL TEXT
Vitamin D and the Cardiovascular System
Artaza et al.
CJASN 2009;4:1515-1522.
ABSTRACT
| FULL TEXT
25-Hydroxyvitamin D Levels Inversely Associate with Risk for Developing Coronary Artery Calcification
de Boer et al.
J. Am. Soc. Nephrol. 2009;20:1805-1812.
ABSTRACT
| FULL TEXT
Low Calcidiol Levels and Coronary Artery Calcification: True, True, and Related?
Melamed and Thadhani
J. Am. Soc. Nephrol. 2009;20:1663-1665.
FULL TEXT
25-Hydroxyvitamin D Levels and All-Cause Mortality--Reply
Melamed et al.
Arch Intern Med 2009;169:1076-1076.
FULL TEXT
25-Hydroxyvitamin D Levels and All-Cause Mortality
Zittermann and Grant
Arch Intern Med 2009;169:1075-1076.
FULL TEXT
Vitamin D Affects Survival Independently of Vascular Calcification in Chronic Kidney Disease
Barreto et al.
CJASN 2009;4:1128-1135.
ABSTRACT
| FULL TEXT
Calcium Plus Vitamin D Supplementation and Mortality in Postmenopausal Women: The Women's Health Initiative Calcium-Vitamin D Randomized Controlled Trial
LaCroix et al.
J Gerontol A Biol Sci Med Sci 2009;64A:559-567.
ABSTRACT
| FULL TEXT
Vitamin D Deficiency in Critically Ill Patients
Lee et al.
NEJM 2009;360:1912-1914.
FULL TEXT
Association of oral calcitriol with improved survival in non-dialysed and dialysed patients with CKD
Negri
Nephrol Dial Transplant 2009;24:341-344.
FULL TEXT
Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells
Artaza and Norris
J Endocrinol 2009;200:207-221.
ABSTRACT
| FULL TEXT
|
